Perinatal white matter development and fetal hypoxia

围产期白质发育与胎儿缺氧

基本信息

  • 批准号:
    7876870
  • 负责人:
  • 金额:
    $ 44.73万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-01 至 2012-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cerebral palsy (CP) is the leading cause of neurological disability in survivors of neonatal intensive care. The impediments to progress have been a lack of a suitable animal model of CP and a lack of diagnostic tools of fetal brain injury; both are addressed in this proposal. We will utilize a clinically relevant fetal animal mode mimicking acute placental insufficiency recently developed by us, which exhibits a CP phenotype in newborn rabbit pups following fetal hypoxia-ischemia (H-l) at 70% gestation. We have previously shown that reactive oxygen (ROS) and reactive nitrogen species (RNS) are produced in fetal brain after H-l in this model, and administration of antioxidants to the mother ameliorates fetal brain injury and reverses hypertonia. Pilot studies show that white matter (WM) injury accompanied by death of oligodendrocyte (OL) precursors is produced by the H-l insult. Our approach focuses on cellular and molecular determinants of preterm cerebral white matter injury and its sequelae and uses a multidisciplinary innovative approach, integrating recent advances in immunohistochemistry, flow cytometry, magnetic resonance imaging (MRI) electrophysiology, myelination and oxidant biochemistry. Our hypothesis is that the predilection of the preterm white matter to injury from H-l is related to a maturation-dependent vulnerability of OL precursors whose death is a pathogenic factor in the genesis of subsequent myelination disturbances. We will also test the hypothesis that the vulnerability of OL precursors to H-l is related to production of reactive oxygen and nitrogen species in fetal brain. The specific aims are to determine: (1) whether neurobehavioral changes, specifically hypertonia at P1, induced by fetal H-l, are associated with white matter injury. (2) whether death of OL precursors from H-l is associated with subsequent injury to fiber tracts in the white matter. (3) the role of reactive oxygen and nitrogen species in OL precursor and white matter injury at premature gestation. Our objectives are to understand the factors that predispose OL precursors to death from H-l and to establish whether there is a causal relationship between OL death in vivo and the genesis of cerebral myelination disturbances. Upon completion of this project, we hope to gain insight into strategies to prevent white matter injury by understanding intrinsic features of the OL which influence susceptibility to H-l. Efficacy of better clinical and biochemical markers of white matter injury including non-invasive MRI measures and safe, non-toxic therapies aimed at the fetus but administered to the mother will be tested.
描述(由申请人提供):脑瘫(CP)是新生儿重症监护幸存者神经功能障碍的主要原因。进展的障碍是缺乏合适的CP动物模型和缺乏胎儿脑损伤的诊断工具;这两个问题都在本提案中得到了解决。我们将利用我们最近开发的模拟急性胎盘功能不全的临床相关胎儿动物模型,其在70%妊娠的胎儿缺氧-缺血(H-1)后的新生兔幼仔中表现出CP表型。我们以前已经表明,活性氧(ROS)和活性氮(RNS)在胎儿脑中产生H-1后,在这个模型中,和抗氧化剂的母亲改善胎儿脑损伤和逆转张力亢进的管理。初步研究表明,白色物质(WM)损伤伴随着少突胶质细胞(OL)前体的死亡是由H-1损伤产生的。我们的方法集中于早产儿脑白色损伤及其后遗症的细胞和分子决定因素,并采用多学科创新方法,整合免疫组织化学,流式细胞术,磁共振成像(MRI)电生理学,髓鞘形成和氧化剂生物化学的最新进展。我们的假设是,早产儿白色物质对H-1损伤的偏好与OL前体的成熟依赖性脆弱性有关,OL前体的死亡是随后髓鞘形成障碍发生的致病因素。我们还将检验以下假设:OL前体对H-1的脆弱性与胎儿脑中活性氧和氮的产生有关。具体目的是确定:(1)胎儿H-1诱导的神经行为变化,特别是P1时的张力亢进,是否与白色物质损伤相关。(2)来自H-1的OL前体的死亡是否与随后对白色物质中纤维束的损伤有关。(3)活性氧和氮在早产儿OL前体和白色物质损伤中的作用我们的目标是了解导致OL前体死亡的因素,并确定体内OL死亡与脑髓鞘形成障碍的发生之间是否存在因果关系。在完成该项目后,我们希望通过了解影响对H-1敏感性的OL的内在特征来深入了解预防白色物质损伤的策略。将测试更好的白色损伤的临床和生化标志物的有效性,包括针对胎儿但给予母亲的非侵入性MRI测量和安全无毒治疗。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SIDHARTHA TAN其他文献

SIDHARTHA TAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SIDHARTHA TAN', 18)}}的其他基金

Ferroptosis in knock-in sepiapterin reductase mutation rabbits
敲入墨蝶呤还原酶突变兔的铁死亡
  • 批准号:
    10747716
  • 财政年份:
    2023
  • 资助金额:
    $ 44.73万
  • 项目类别:
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits
利用转基因兔探讨四氢生物蝶呤在脑瘫中的作用
  • 批准号:
    10530589
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Neuroprotection by nNOS inhibitors in perinatal hypoxia-ischemia
nNOS 抑制剂对围产期缺氧缺血的神经保护作用
  • 批准号:
    10152683
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Neuroprotection by nNOS inhibitors in perinatal hypoxia-ischemia
nNOS 抑制剂对围产期缺氧缺血的神经保护作用
  • 批准号:
    10651613
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Neuroprotection by nNOS inhibitors in perinatal hypoxia-ischemia
nNOS 抑制剂对围产期缺氧缺血的神经保护作用
  • 批准号:
    10358576
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Neuroprotection by nNOS inhibitors in perinatal hypoxia-ischemia
nNOS 抑制剂对围产期缺氧缺血的神经保护作用
  • 批准号:
    10066816
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Probing Role of Tetrahydrobiopterin in Cerebral Palsy by Using Transgenic Rabbits
利用转基因兔探讨四氢生物蝶呤在脑瘫中的作用
  • 批准号:
    10312139
  • 财政年份:
    2020
  • 资助金额:
    $ 44.73万
  • 项目类别:
Non-apoptotic cell death in fetal brain injury
胎儿脑损伤中的非凋亡细胞死亡
  • 批准号:
    9512303
  • 财政年份:
    2017
  • 资助金额:
    $ 44.73万
  • 项目类别:
Tetrahydrobiopterin in Fetal Hypoxic Brain Injury
四氢生物蝶呤在胎儿缺氧性脑损伤中的作用
  • 批准号:
    9304605
  • 财政年份:
    2016
  • 资助金额:
    $ 44.73万
  • 项目类别:
Tetrahydrobiopterin in Fetal Hypoxic Brain Injury
四氢生物蝶呤在胎儿缺氧性脑损伤中的作用
  • 批准号:
    8717742
  • 财政年份:
    2013
  • 资助金额:
    $ 44.73万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.73万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了